| TTM
|
7/31/2026
|
7/31/2025
|
7/31/2024
|
7/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
11,480,000 | 11,480,000 | 9,221,000 | 8,027,000 | 6,892,700 |
| Cost of Revenue
|
-3,403,000 | -3,403,000 | -2,451,000 | -2,059,000 | -1,909,700 |
|
Gross Profit
|
8,077,000 | 8,077,000 | 6,770,000 | 5,968,000 | 4,983,000 |
| Selling, General and Administrative Expenses
|
-4,830,000 | -4,830,000 | -3,543,000 | -3,474,000 | -2,991,700 |
|
Research and Development Expenses
|
-2,552,000 | -2,552,000 | -1,984,000 | -1,810,000 | -1,604,000 |
|
Operating Income/Expenses
|
-7,382,000 | -7,382,000 | -5,527,000 | -5,284,000 | -4,595,700 |
|
Total Operating Profit/Loss
|
695,000 | 695,000 | 1,243,000 | 684,000 | 387,300 |
| Total Net Finance Income/Expense
|
374,000 | 374,000 | 361,000 | 310,000 | 197,200 |
| Net Investment Income
|
23,000 | 23,000 | -33,000 | 0 | -7,900 |
|
Other Income/Expense, Non-Operating
|
-556,000 | -556,000 | 25,000 | -6,000 | -10,300 |
|
Non-Operating Income/Expenses, Total
|
-159,000 | -159,000 | 353,000 | 304,000 | 179,000 |
|
Pretax Income
|
536,000 | 536,000 | 1,596,000 | 988,000 | 566,300 |
|
Provision for Income Tax
|
-229,000 | -229,000 | -462,000 | 1,590,000 | -126,600 |
|
Net Income from Continuing Operations
|
307,000 | 307,000 | 1,134,000 | 2,578,000 | 439,700 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
307,000 | 307,000 | 1,134,000 | 2,578,000 | 439,700 |
|
Net Income after Non-Controlling/Minority Interests
|
307,000 | 307,000 | 1,134,000 | 2,578,000 | 439,700 |
|
Net Income Available to Common Stockholders
|
307,000 | 307,000 | 1,134,000 | 2,578,000 | 439,700 |
|
Diluted Net Income Available to Common Stockholders
|
307,000 | 307,000 | 1,134,000 | 2,578,000 | 439,700 |
| Basic EPS
|
0.41 | 0.41 | 1.71 | 4.04 | 0.73 |
| Diluted EPS
|
0.40 | 0.40 | 1.60 | 3.64 | 0.64 |
|
Basic Weighted Average Shares Outstanding
|
749,000 | 749,000 | 663,000 | 638,000 | 606,400 |
|
Diluted Weighted Average Shares Outstanding
|
764,000 | 764,000 | 709,000 | 708,000 | 684,500 |
|
Reported Normalized Diluted EPS
|
3.84 | 3.84 | 3.34 | 2.83 | 2.22 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
162,000 | 162,000 | 1,235,000 | 678,000 | 362,400 |
|
EBITDA
|
1,017,000 | 1,017,000 | 1,578,000 | 962,000 | 644,600 |
|
Normalized EBITDA
|
3,371,000 | 3,371,000 | 2,938,000 | 2,094,000 | 1,769,000 |
|
Normalized Income
|
2,931,000 | 2,931,000 | 2,100,960 | 3,472,280 | 1,440,000 |
|
Total Unusual Items
|
2,354,000 | 2,354,000 | 1,360,000 | 1,132,000 | 1,124,400 |
|
Total Unusual Items Excluding Goodwill
|
2,354,000 | 2,354,000 | 1,360,000 | 1,132,000 | 1,124,400 |
7/31/2023 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade